TB maintains its rank as the first leading cause of death in South Africa, a position that it has held since 1997. In 2011 10,7% of deaths are due to tuberculosis.

New surveillance data published by the European Centre for Disease Prevention and Control and the WHO Regional Office for Europe ahead of World Tuberculosis Day.

Give your support by signing here: http://www.msfaccess.org/TBmanifesto/.

Activists demand rapid completion of intellectual property policy six years in the making; without internationally recognised public health safeguards policy will be health disaster.

Prevention of infection study underway in South Africa.

South Africa is battling to reduce its cases of multidrug-resistant TB with the success rate for those on treatment at about 40 percent.

Otsuka's response to open letter regarding delamanid compassionate use program.

The Global Fund Communities Delegation abstained from the decision point on the Transition from the 3rd to 4th Replenishment Period.

The need for a highly sensitive and specific affordable point-of-care TB test remains urgent.

Under the provisions of the conditional approval, Janssen commits to support a Phase 3 study to further substantiate the benefit-risk for SIRTURO^® and define its optimal use.